TNF and rheumatoid arthritis: In RA, the attenuation of inflammatory joint disease through the administration of anti-TNF-α therapy, or probably any powerful disease-modifying antirheumatic drug, is associated with a concomitant reduction in the risk of cardiovascular events [6].